biote Corp. is a woman-led company, which engages in providing bio identical hormone pellet therapy. The company is headquartered in Irving, Texas and currently employs 223 full-time employees. The company went IPO on 2021-03-02. The firm provides the necessary components to enable Biote-certified practitioners to establish, build and implement a program designed to optimize hormone levels using personalized solutions for their patient populations. The Biote Method is a comprehensive, end-to-end practice building platform that provides Biote-certified practitioners with the components specifically developed for practitioners in the hormone optimization space: Biote Method education, training and certification, practice management software, inventory management software, and information regarding available hormone replacement therapy (HRT) products, as well as digital and point-of-care marketing support. The company also sells a complementary Biote-branded line of dietary supplements. The Biote Method’s proprietary clinical decision support (CDS) software assists physicians in establishing individualized dosing for patients.
Mr. Bret Christensen est le Chief Executive Officer de Biote Corp, il a rejoint l'entreprise depuis 2025.
Quelle est la performance du prix de l'action BTMD ?
Le prix actuel de BTMD est de $2.21, il a diminué de 0% lors de la dernière journée de trading.
Quels sont les thèmes d'affaires principaux ou les industries de Biote Corp ?
Biote Corp appartient à l'industrie Pharmaceuticals et le secteur est Health Care
Quel est la capitalisation boursière de Biote Corp ?
La capitalisation boursière actuelle de Biote Corp est de $86.8M
Est-ce que Biote Corp est un achat, une vente ou un maintien ?
Selon les analystes de Wall Street, 7 analystes ont établi des notations d'analystes pour Biote Corp, y compris 3 achat fort, 6 achat, 2 maintien, 0 vente et 3 vente forte